Home > Patient ResourcesHuman Papilloma Virus (HPV) Vaccine

 

 

Human Papilloma Virus (HPV) Vaccine

 

I am older than 27 years, can I still be vaccinated?

 

HPV vaccine is not FDA approved for use in women 27 years of age or older and most insurance companies will not pay for it. However, studies have shown that the vaccine does work to prevent infection with HPV types covered by the vaccine (HPV16 or 18 for Cervarix by and HPV 6, 11, 16 or 18 for Gardasil) in women who have not been previously infected. The question is not whether the vaccine will work in these women but whether they will benefit from vaccination. In the United States, cervical cancer is primarily prevented by screening (with Pap tests or a combination of Pap and HPV tests). The main benefit to HPV vaccination is preventing cervical precancer (high-grade cervical intraepithelial neoplasia (HGCIN), CIN-2, CIN-3, moderate dysplasia, severe dysplasia, carcinoma in situ) that will need to be treated since treatment (LEEP) significantly increases the risk of premature labor in a future pregnancy. By preventing the need for LEEP, HPV vaccine eliminates this increased risk of premature labor. It also reduces the number of colposcopies and treatments and the anxiety associated with getting an abnormal Pap test. Although some women older than 27 years might benefit from the HPV vaccine most will not. Anyone who has completed her childbearing will get minimal benefit and should not be vaccinated.